Skip to content

Management of wounds with Ayurveda herbal drug.

A Clinical study of Thumari(Securinega leucopyrus)gel in the management of dusta vrana wsr to chronic wound

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/08/007145
Enrollment
80
Registered
2016-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- DUSTA VRANA (DIABETIC ULCER,VENOUS ULCER,PRESSURE ULCER)

Interventions

Intervention1: THUMARI(SECURINEGA LEUCOPYRUS)GEL: SUFFICIENT AMOUNT OF GEL TO COVER THE ULCER FOR DAILY EXTERNAL DRESSING OF ULCER FOR 30 DAYS FOLLOW UP I MONTH Control Intervention1: BETADINE OINTMEN

Sponsors

POST GRADUATE TEACHING HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: DIAGNOSED CASE OF DUSTA VRANA WITH REFERENCE TO CHRONIC WOUNDS LIKE DIABETIC ULCER,VENOUS ULCER,PRESSURE ULCERS.

Exclusion criteria

Exclusion criteria: PAST HISTORY OF TUBERCULOSIS UNCONTROLLED HYPERTENSION HEART DISEASES LIKE MI, CAD, IHD AGE BELOW 18 AND ABOVE 70 YEARS. PATIENTS WITH AIDS & STD

Design outcomes

Primary

MeasureTime frame
Relief in sign and symptoms of wound Healing of wound Reduction in size of wound Neovascularization peripheral skin color changes to normal Healthy granulationTimepoint: 30 days

Secondary

MeasureTime frame
BETTERMENT OF WOUND CONTRACTION AND THE COMPLETE WOUND HEALING WILL BE OBSERVED WITH MINOR OR NO SCAR ALONG WITH RE-PIGMENTATION OF THE NEW TISSUETimepoint: 30 DAYS

Countries

India

Contacts

Public ContactDR T S DUDHAMAL

INSTITUTE FOR POST GRADUATE TEACHING AND RESEARCH IN AYURVEDA JAMNAGAR

drghodela@gmail.com9460304832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026